Nath Bio-Genes (I)

quarterly
yearly
ParticularsDec '21Mar '22Jun '22Sep '22Dec '22
Revenue21.6627.21209.3521.7325.30
Expenses16.33138.30175.5817.6520.36
EBITDA5.33-111.0933.774.084.94
EBIT4.65-112.1433.103.414.27
Profit Before Tax2.91-112.8330.921.532.04
Net Profit2.81-116.2930.761.471.35
Financial Ratios
Operating Profit Margin24.61%-408.27%16.13%18.78%19.53%
Net Profit Margin12.97%-427.38%14.69%6.76%5.34%
Earning Per Share (Diluted)1.48-30.8216.180.770.71
Dividends Per ShareNA2.00NANANA
ⓒ 2016-2023 Groww. All rights reserved, Built with in India
MOST POPULAR ON GROWWVERSION - 3.7.9
STOCK MARKET INDICES:  S&P BSE SENSEX |  S&P BSE 100 |  NIFTY 100 |  NIFTY 50 |  NIFTY MIDCAP 100 |  NIFTY BANK |  NIFTY NEXT 50
MUTUAL FUNDS COMPANIES:  ICICI PRUDENTIAL |  HDFC |  NIPPON INDIA |  ADITYA BIRLA SUN LIFE |  SBI |  UTI |  FRANKLIN TEMPLETON |  KOTAK MAHINDRA |  IDFC |  DSP |  AXIS |  TATA |  L&T |  SUNDARAM |  PGIM |  INVESCO |  LIC |  JM FINANCIAL |  BARODA PIONEER |  CANARA ROBECO |  HSBC |  IDBI |  INDIABULLS |  MOTILAL OSWAL |  BNP PARIBAS |  MIRAE ASSET |  PRINCIPAL |  BOI AXA |  UNION KBC |  TAURUS |  EDELWEISS |  NAVI |  MAHINDRA |  QUANTUM |  PPFAS |  IIFL |  Quant |  SHRIRAM |  SAHARA |  ITI